Bnp Paribas Asset Management Holding S.A. Revolution Medicines, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,276 shares of RVMD stock, worth $44,660. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,276Holding current value
$44,660% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RVMD
# of Institutions
312Shares Held
188MCall Options Held
186KPut Options Held
672K-
Vanguard Group Inc Valley Forge, PA16.6MShares$581 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$474 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$469 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$413 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$357 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.07B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...